Clearside Biomedical, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Clearside Biomedical, Inc. reported Cash And Cash Equivalents At Carrying Value of $20.02 million for the year ending 2024.

  • Clearside Biomedical, Inc. showed a decrease of -30.8% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
  • XBRL data for this metric is available from 2013 to 2024 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2013 to 2024), Clearside Biomedical, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 948.7%.
  • Historical annual values: Fiscal year 2024: $20.02 million | Fiscal year 2023: $28.92 million | Fiscal year 2022: $48.26 million | Fiscal year 2021: $30.44 million | Fiscal year 2020: $17.29 million | Fiscal year 2019: $22.60 million | Fiscal year 2018: $8.04 million | Fiscal year 2017: $9.22 million | Fiscal year 2016: $34.82 million | Fiscal year 2015: $20.28 million | Fiscal year 2014: $8.27 million | Fiscal year 2013: $1.91 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: